Large-scale testing (Phase 3)Study completedNCT00111449What this trial is testingEvaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With PsoriasisWho this might be right forPsoriasis Amgen 600
Not applicableActive Not RecruitingNCT06362148What this trial is testingCirculating Tumor DNA in Peripheral T-cell LymphomasWho this might be right forPeripheral T-cell LymphomaNK/T-Cell Lymphoma University of Aarhus 50
Testing effectiveness (Phase 2)Ended earlyNCT01685021What this trial is testingStudy of Fc-Optimized Anti-CD19 Antibody (MOR00208) to Treat B-cell Acute Lymphoblastic Leukemia(B-ALL)Who this might be right forAcute Lymphoblastic Leukemia MorphoSys AG 22
Early research (Phase 1)Study completedNCT02594384What this trial is testingA Phase I Dose Escalation Study of the Safety and Pharmacokinetics of LAM-002A In Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma, Non-Hodgkin; Leukemia, Chronic Lymphocytic OrphAI Therapeutics 62
Early research (Phase 1)Ended earlyNCT01644253What this trial is testingPhase 1b Safety and Efficacy Study of TRU-016Who this might be right forChronic Lymphocytic LeukemiaPeripheral T-cell Lymphoma Aptevo Therapeutics 87
Very early researchUnknownNCT04626739What this trial is testingCAR-T Cells in Treating Patients With Relapsed or Refractory NHLWho this might be right forRefractory Indolent Adult Non-Hodgkin Lymphoma Hebei Senlang Biotechnology Inc., Ltd. 100
Testing effectiveness (Phase 2)Study completedNCT00144807What this trial is testingACVBP Plus Rituximab in Patients Aged From 18 to 59 Years With High-risk Diffuse Large B-cell LymphomaWho this might be right forDiffuse Large Cell Lymphoma Lymphoma Study Association 128
Testing effectiveness (Phase 2)Study completedNCT00066092What this trial is testingPegfilgrastim PBPC Mobilization StudyWho this might be right forLymphomaHodgkin's LymphomaNon-Hodgkin's Lymphoma+2 more Amgen 41
Testing effectiveness (Phase 2)Looking for participantsNCT03587844What this trial is testingDosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome PatientsWho this might be right forMycosis FungoidesLymphomatoid PapulosisSezary Syndrome Memorial Sloan Kettering Cancer Center 58
Not applicableLooking for participantsNCT07652580What this trial is testingToxin Exposure and Immune Dysregulation in Non-Hodgkin LymphomaWho this might be right forNon-Hodgkin LymphomaLymphoma Non-HodgkinB-cell Lymphoma+1 more Henry M. Jackson Foundation for the Advancement of Military Medicine 300
Early research (Phase 1)Study completedNCT00002946What this trial is testingPenclomedine in Treating Patients With Solid Tumors or LymphomaWho this might be right forLymphomaUnspecified Adult Solid Tumor, Protocol Specific National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)UnknownNCT04500561What this trial is testingYY-20394 、GEMOX Treatment Diffuse Large B-cell Lymphoma Single Arm, Open, Multicentrized Phase 1b/2 Clinical TrialWho this might be right forDiffuse Large B Cell Lymphoma Shanghai YingLi Pharmaceutical Co. Ltd. 28
Early research (Phase 1)Study completedNCT04103905What this trial is testingMIL62 in Treatment of CD20 Positive B-cell LymphomasWho this might be right forCD20-positive B Cell Non-Hodgkin Lymphoma Beijing Mabworks Biotech Co., Ltd. 27
Not applicableEnded earlyNCT00925405What this trial is testingBreast Magnetic Resonance Imaging (MRI) Screening After Mantle Radiation TherapyWho this might be right forBreast Cancer M.D. Anderson Cancer Center 10
Not applicableLooking for participantsNCT05705531What this trial is testingA Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin LymphomaWho this might be right forCardiovascular DisorderClassic Hodgkin LymphomaClonal Hematopoiesis Children's Oncology Group 190
Early research (Phase 1)Ended earlyNCT00848601What this trial is testingSafety of SGI-1776, A PIM Kinase Inhibitor in Refractory Prostate Cancer and Relapsed/Refractory Non Hodgkin's LymphomaWho this might be right forProstate CancerNon-Hodgkins Lymphoma Astex Pharmaceuticals, Inc. 14
Not applicableStudy completedNCT04396119What this trial is testingDeveloping Lung Cancer Screening in Hodgkin Lymphoma Survivors: a Qualitative StudyWho this might be right forHodgkin Lymphoma The Christie NHS Foundation Trust 30
Testing effectiveness (Phase 2)Looking for participantsNCT07473167What this trial is testingStudy of Safety and Efficacy of TC011 in the Relapsed/Refractory Large B Cell Non-Hodgkin Lymphoma PatientsWho this might be right forRelapsed Large B-cell LymphomaRefractory Large B-cell LymphomaDiffuse Large B-cell Lymphoma (DLBCL)+3 more TICAROS Co., Ltd. 98
Testing effectiveness (Phase 2)Study completedNCT00002501What this trial is testingCyclophosphamide and Filgrastim in Treating Patients With Stage IV, Relapsed, or Refractory Low-Grade Follicular Non-Hodgkin's LymphomaWho this might be right forLymphoma Alliance for Clinical Trials in Oncology 29
Early research (Phase 1)Active Not RecruitingNCT06824701What this trial is testingTazemetostat in Combination With Zanubrutinib and Anti-CD20 Monoclonal Antibody in Relapsed or Refractory B-cell Non-Hodgkin LymphomaWho this might be right forRelapsed or Refractory B-cell Non-Hodgkin Lymphoma University of Utah 24